mRNA CONFERENCE EUROPE 2026

Welcome to the European mRNA Conference 2026, where global pharmaceutical and biotechnology leaders meet industry experts to explore innovations in mRNA therapeutics for vaccines, personalised medicine, and beyond.

This event explores the role of mRNA technology in developing novel treatments, covering research and development, clinical trials, large-scale manufacturing, and commercialisation. It highlights advances in RNA modification, therapeutic delivery systems, and vaccine development, showcasing the latest progress in mRNA medicine and oligonucleotide therapeutics.

Join us to explore next-generation mRNA therapeutics, gain valuable insights, and work together to shape the future of medicine.

Future of mRNA-based therapeutics in infectious diseases and other areas

Explore the potential of mRNA therapeutics as a revolutionary new class of drugs.

Breakthrough research on mRNA medicines and oligonucleotide therapeutics

Understand how the latest developments in mRNA medicine and oligonucleotide therapeutics are transforming the advanced therapies industry worldwide.

Manufacturing challenges in global mRNA vaccine production

Examine cutting-edge strategies for the rapid development and large-scale deployment of vaccines to effectively respond to global pandemics.

Latest advancements in mRNA formulation and delivery technologies

Learn about the latest technological advancements in therapeutic mRNA delivery, tracing the journey from laboratory research to successful clinical application.

Data-driven strategies using AI and ML in mRNA therapeutic design

Discover how advanced AI and ML algorithms, supported by powerful data analytics, are accelerating therapeutic design and revealing novel biomedical insights.

Regulatory and compliance considerations in mRNA clinical development

Grasp key regulatory and commercial considerations shaping the approval pathway of mRNA therapeutics.

Expert Speakers

Past Attendees